Indian Pharmaceuticals & Biotech Stable Growth Stocks

Ajanta Pharma

Market Cap: ₹442.2b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

Emcure Pharmaceuticals

Market Cap: ₹381.0b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Neuland Laboratories

Market Cap: ₹288.7b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Acutaas Chemicals

Market Cap: ₹258.2b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Granules India

Market Cap: ₹214.4b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.

Lupin

Market Cap: ₹1.0t

Operates as a pharmaceutical company in India, the United States, and internationally.

Aurobindo Pharma

Market Cap: ₹959.2b

A pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally.

Aether Industries

Market Cap: ₹214.0b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Sai Life Sciences

Market Cap: ₹310.5b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

Rubicon Research

Market Cap: ₹273.7b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Abbott India

Market Cap: ₹598.1b

Operates as a pharmaceutical company in India.

Anthem Biosciences

Market Cap: ₹494.7b

Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.

Biocon

Market Cap: ₹692.2b

Manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹443.8b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.